Literature DB >> 30747620

Host and pathogen factors in Klebsiella pneumoniae upper urinary tract infections in renal transplant patients.

Justyna E Gołębiewska1, Beata Krawczyk2, Magdalena Wysocka2, Aleksandra Ewiak3, Jolanta Komarnicka3, Marek Bronk3, Bolesław Rutkowski1, Alicja Dębska-Ślizień1.   

Abstract

PURPOSE: To analyse the role of virulence factors (VFs) and host in Klebsiella pneumoniae upper urinary tract infections (UTIs) in renal transplant (RTx) recipients.
METHODOLOGY: Clinical and demographic data were registered prospectively. Phylogenetic background of K. pneumoniae isolates was analysed by PCR melting profiles (MP) and the following VFs genes: fimH-1, uge, kpn, ycfM, mrkD, rmpA, magA, hlyA, cnf-1, irp-1, irp-2, fyuA, entB, iutA, iroN by PCR.
RESULTS: We studied urine cultures and clinical data from 61 episodes of K. pneumoniae UTI in 54 RTx recipients. There were 32 cases of AB (53%), 10 cases of lower UTI (16%), 19 cases of AGPN (31%), including six cases of bacteraemia. In total, 74 % of strains were extended-spectrum beta-lactamase+, and there were two carbapenemase-producing strains. PCR MP typing showed a diverse population with 52 different genetic profiles of K. pneumoniae. Analysis of the DNA profiles indicated 45 unrelated, unique genotypes and 7 related (16 isolates from 15 patients) genotypes. Urine flow impairment emerged as an independent predictor of K. pneumoniae upper UTIs (OR 14.28, CI 2.7-75.56, P 0.002), while we did not find any association between the profile of VFs and developing upper UTIs. The prevalence of the uge gene was lower in RTx patients on everolimus when compared to isolates from patients not receiving mTOR inhibitors (33.3 % vs 82.8 % P<0.05).
CONCLUSIONS: K. pneumoniae upper UTI may be a marker of urine flow impairment. Bacterial VFs could not discriminate between upper and lower UTIs. However, immunosuppression may influence the selection of particular VFs.

Entities:  

Keywords:  Klebsiella pneumoniae; host factors; renal transplant; urinary tract infection; virulence factors

Mesh:

Substances:

Year:  2019        PMID: 30747620     DOI: 10.1099/jmm.0.000942

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Genetic Background and Antibiotic Resistance Profiles of K. pneumoniae NDM-1 Strains Isolated from UTI, ABU, and the GI Tract, from One Hospital in Poland, in Relation to Strains Nationally and Worldwide.

Authors:  Magdalena Wysocka; Roxana Zamudio; Marco R Oggioni; Justyna Gołębiewska; Marek Bronk; Beata Krawczyk
Journal:  Genes (Basel)       Date:  2021-08-22       Impact factor: 4.096

2.  Prevalence, serotyping and drug susceptibility patterns of Escherichia coli isolates from kidney transplanted patients with urinary tract infections.

Authors:  Atefeh Najafi Khah; Mojdeh Hakemi-Vala; Shiva Samavat; Mohammad Javad Nasiri
Journal:  World J Biol Chem       Date:  2020-11-27

3.  The New Klebsiella pneumoniae ST152 Variants with Hypermucoviscous Phenotype Isolated from Renal Transplant Recipients with Asymptomatic Bacteriuria-Genetic Characteristics by WGS.

Authors:  Magdalena Wysocka; Roxana Zamudio; Marco R Oggioni; Justyna Gołębiewska; Aleksandra Dudziak; Beata Krawczyk
Journal:  Genes (Basel)       Date:  2020-10-13       Impact factor: 4.096

4.  Antibiotic Resistance of Uropathogens Isolated from Patients Hospitalized in District Hospital in Central Poland in 2020.

Authors:  Barbara Kot; Agata Grużewska; Piotr Szweda; Jolanta Wicha; Urszula Parulska
Journal:  Antibiotics (Basel)       Date:  2021-04-16

Review 5.  Urinary Tract Infections Caused by K. pneumoniae in Kidney Transplant Recipients - Epidemiology, Virulence and Antibiotic Resistance.

Authors:  Beata Krawczyk; Magdalena Wysocka; Michał Michalik; Justyna Gołębiewska
Journal:  Front Cell Infect Microbiol       Date:  2022-04-21       Impact factor: 5.293

6.  Changes of urine isolates of Escherichia coli and Klebsiella pneumoniae biofilm affect monocytes' response.

Authors:  Agnieszka Daca; Justyna Gołębiewska; Marek Bronk; Tomasz Jarzembowski
Journal:  World J Microbiol Biotechnol       Date:  2021-09-28       Impact factor: 3.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.